Proceedings of the International Conference “Health and wellbeing in modern society” (ICHW 2020)

<Previous Article In Volume
Next Article In Volume>

Strategies and Problems of Pharmaceutical Industry Development in the Context of an Increased State Regulation

Authors
L.A. Ashikhina, N.V. Lisichkina, L.S. Bolshakova, Ju.G. Goloktionova, E.V. Izvekova, A.V. Kuzina, O.L. Ladnova, E.G. Merkulova
Corresponding Author
L.A. Ashikhina
Available Online 3 October 2020.
DOI
10.2991/ahsr.k.201001.046How to use a DOI?
Keywords
pharmaceutical industry, health care, state regulation, R&D investment
Abstract

Transition to a new technological mode not only leads to the emergence of new opportunities and directions of industrial development, but also causes the need for the formation of new innovative ways of production and commercial activities, the creation of new forms and technologies of enterprise management. The choice of strategy for the development of Russian pharmaceuticals in a new industrialization is complicated by the specifics of the industry. On the one hand, pharmaceutical companies, as a part of the health care system, are uniquely valuable for society and carry an extremely important mission. Innovative medicines developed today, without exaggeration, can change the future of mankind. On the other hand, the production and circulation of pharmaceutical products in Russia is under strict control of the state. The strengthening of state regulation artificially restricts the use of innovative sales technologies and non-traditional sales channels. This leads to a systematic and long-term decline in profitability, which negatively affects the investment attractiveness of the industry.

Copyright
© 2020, the Authors. Published by Atlantis Press.
Open Access
This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

<Previous Article In Volume
Next Article In Volume>
Volume Title
Proceedings of the International Conference “Health and wellbeing in modern society” (ICHW 2020)
Series
Advances in Health Sciences Research
Publication Date
3 October 2020
ISBN
10.2991/ahsr.k.201001.046
ISSN
2468-5739
DOI
10.2991/ahsr.k.201001.046How to use a DOI?
Copyright
© 2020, the Authors. Published by Atlantis Press.
Open Access
This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Cite this article

risenwbib
TY  - CONF
AU  - L.A. Ashikhina
AU  - N.V. Lisichkina
AU  - L.S. Bolshakova
AU  - Ju.G. Goloktionova
AU  - E.V. Izvekova
AU  - A.V. Kuzina
AU  - O.L. Ladnova
AU  - E.G. Merkulova
PY  - 2020
DA  - 2020/10/03
TI  - Strategies and Problems of Pharmaceutical Industry Development in the Context of an Increased State Regulation
BT  - Proceedings of the International Conference “Health and wellbeing in modern society” (ICHW 2020)
PB  - Atlantis Press
SP  - 229
EP  - 232
SN  - 2468-5739
UR  - https://doi.org/10.2991/ahsr.k.201001.046
DO  - 10.2991/ahsr.k.201001.046
ID  - Ashikhina2020
ER  -